~25 spots leftby Apr 2026

Sound Coding Strategies for Hearing Loss

Recruiting in Palo Alto (17 mi)
Overseen byDavid M Landsberger, MD
Age: Any Age
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: NYU Langone Health
No Placebo Group

Trial Summary

What is the purpose of this trial?

The purpose of this study is to understand performance with a cochlear implant. The long-term goals of this research are to improve sound perception with cochlear implants and to better understand the functioning of the auditory system. Information from individuals with and without cochlear implants will be compared.

Eligibility Criteria

This trial is for children and adults with cochlear implants implanted before age 2, those who have some hearing left with aids, or normal hearing. It's open to ages 7-35 if pre-lingually implanted and 18+ for post-lingual implantation or normal hearing. Post-lingually implanted children cannot participate.

Inclusion Criteria

I am 7 or older and got a cochlear implant before age 2, or I can hear with aids or normally.
I am 18 or older with either a cochlear implant received after learning to speak or normal hearing.
I am between 18 and 35 years old and received my implant before I could speak.

Exclusion Criteria

Children who got a cochlear implant after they learned to speak.

Treatment Details

Interventions

  • Cochlear Implant (Procedure)
  • Electric-only Spectral Resolution (Behavioural Intervention)
  • Modulation Detection Threshold (MDT) and Gap Detection Tasks (Behavioural Intervention)
  • Single-Electrode Pulse Train (Behavioural Intervention)
  • Sound Coding Strategy (Behavioural Intervention)
Trial OverviewThe study tests how different sound coding strategies in cochlear implants affect auditory performance. Participants will try electric-only spectral resolution methods and single-electrode pulse trains to see which improves sound perception.
Participant Groups
6Treatment groups
Experimental Treatment
Active Control
Group I: Late Adult Cochlear Implant (LateAdultCI)Experimental Treatment3 Interventions
Post-lingually implanted adults, 18+ years
Group II: Early Child Cochlear Implant (EarlyChildCI)Experimental Treatment3 Interventions
Early implanted children, ages 7-17 years
Group III: Early Adult Cochlear Implant (EarlyAdultCI)Experimental Treatment2 Interventions
Early implanted adults, ages 18 to 35 years
Group IV: Cochlear Implant (CI)Experimental Treatment1 Intervention
CI children, ages 7-17 years, with aided residual hearing (bimodal/contralateral, electric+acoustic/ipsilateral)
Group V: Normal Hearing Adults (NHA)Active Control1 Intervention
18+ years, Control Group
Group VI: Normal Hearing Children (NHC)Active Control1 Intervention
Ages 7-17 years, Control Group

Cochlear Implant is already approved in United States, European Union for the following indications:

🇺🇸 Approved in United States as Cochlear Implant for:
  • Single-sided deafness (SSD) in children aged 5 years and older
  • Severe to profound sensorineural hearing loss in both ears
🇪🇺 Approved in European Union as Cochlear Implant for:
  • Severe to profound sensorineural hearing loss in both ears
  • Single-sided deafness (SSD) in children and adults

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
NYU Langone HealthNew York, NY
Loading ...

Who Is Running the Clinical Trial?

NYU Langone HealthLead Sponsor

References